12:00 AM
 | 
Jul 29, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Opexa amends follow-on

Opexa Therapeutics Inc. (NASDAQ:OPXA), The Woodlands, Texas
Business: Autoimmune, Gene/Cell therapy
Date announced: 7/22/13
Type: Follow-on
To be...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >